BELLEVUE GROUP AG – Horizon Therapeutics Public Limited Company Transaction History
BELLEVUE GROUP AG portfolio value:
$18.68M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
-22.40%
quarter
Horizon Therapeutics Public Limited Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -10.55% | -35.58K shares | -8.23M | $61.89 | 301.85K |
| Q2 2022 | share | Decrease | -2.22% | -7.66K shares | -9.39M | $79.76 | 337.43K |
| Q1 2022 | share | Decrease | -6.38% | -23.5K shares | -3.41M | $105.21 | 345.1K |
| Q4 2021 | share | Decrease | -11.44% | -47.6K shares | -5.87M | $108.26 | 368.6K |
| Q3 2021 | share | Decrease | -0.36% | -1.5K shares | 6.47M | $109.54 | 416.2K |
| Q2 2021 | share | Increase | +2.25% | 9.2K shares | 1.51M | $93.64 | 417.7K |
| Q1 2021 | share | Increase | +7.44% | 28.3K shares | 9.78M | $92.04 | 408.5K |
| Q4 2020 | share | Increase | +391.21% | 302.8K shares | 21.8M | $73.15 | 380.2K |
| Q3 2020 | share | Decrease | -51.07% | -80.8K shares | -2.78M | $77.68 | 77.4K |
| Q2 2020 | share | Decrease | -4.70% | -7.8K shares | 3.87M | $55.58 | 158.2K |
| Q1 2020 | share | Decrease | -47.42% | -149.7K shares | -6.51M | $29.62 | 166K |
| Q4 2019 | share | Decrease | -2.35% | -7.6K shares | 2.62M | $36.2 | 315.7K |
| Q3 2019 | share | Increase | +20.41% | 54.8K shares | 2.34M | $27.23 | 323.3K |
| Q2 2019 | share | Increase | 0.00% | 268.5K shares | 6.46M | $24.06 | 268.5K |